No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
287 |
4. Check minimum number of eventsNone |
287 |
5. Include endpointsNone |
287 |
6. Filter based on genotype QC (FinnGen only) |
277 |
Control definitions (FinnGen only)
- Control exclude
- H7_LIDLACRIMALORBIT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H04
- Name in latin
- Dacryoadenitis
Similar endpoints
↥List of similar endpoints to
Dacryoadenitis
based on the number of shared cases.
Similar with more cases:
- Disorders of lacrimal system
- Disorders of eyelid, lacrimal system and orbit
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2212 | 1511 | 693 |
| Only index persons | 1950 | 1344 | 606 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.02 |
| Only index persons | 0.04 | 0.05 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 53.96 | 56.86 | 47.52 |
| Only index persons | 51.95 | 55.26 | 44.61 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 277 | 196 | 81 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.04 |
| Median age at first event (years) | 54.61 | 54.02 | 56.04 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 287
- Matched controls
- 2870
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H04.0
ICD-10 Finland
Dacryoadenitis
+∞
307.7
260
*
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
280.5
83.2
81
*
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
+∞
56.1
52
*
H04.4
ICD-10 Finland
Chronic inflammation of lacrimal passages
+∞
56.1
52
*
H04.10
ICD-10 Finland
Dry eye syndrome
10.1
54.0
70
89
H04.3
ICD-10 Finland
Acute and unspecified inflammation of lacrimal passages
143.4
46.3
48
*
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
+∞
46.1
43
*
CCD50
NOMESCO Finland
Dacryocystorhinostomy with insertion of tube
+∞
24.3
23
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
3.3
22.5
149
702
H01.0
ICD-10 Finland
Blepharitis
7.5
21.7
33
49
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.3
21.6
169
872
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
5.5
19.6
41
84
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.4
18.4
85
316
TCC30
NOMESCO Finland
Intubation of lacrimal canaliculus/duct
191.3
17.7
18
*
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
191.3
17.7
18
*
36800
ICD-8 Finland
Inflammation of lachrymal glands and ducts, Dacryadenitis acuta. Abscessus glandulae lacrimalis
+∞
15.8
15
*
H02AB06
ATC
prednisolone; systemic
2.8
15.7
168
972
S01GX01
ATC
cromoglicic acid; ophthalmic
3.1
15.6
82
326
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.8
15.5
38
89
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
6.0
13.1
24
43
H02AB04
ATC
methylprednisolone; systemic
3.1
12.3
61
232
J01DB01
ATC
cefalexin; oral
3.6
12.1
254
1950
H02.4
ICD-10 Finland
Ptosis of eyelid
48.8
12.0
14
*
H02.3
ICD-10 Finland
Blepharochalasis
31.5
11.8
15
5
H57.1
ICD-10 Finland
Ocular pain
5.9
11.3
21
38
H16.0
ICD-10 Finland
Corneal ulcer
4.5
9.9
25
60
ZXE00
NOMESCO Finland
One hour or less
2.2
9.6
128
767
F29
ICPC
Eye symptom/complaint other
3.2
9.5
40
137
ZXA00
NOMESCO Finland
Right side
2.3
8.8
92
496
R06AE07
ATC
cetirizine; oral
2.1
8.4
135
858
36801
ICD-8 Finland
Inflammation of lachrymal glands and ducts, Dacryadenitis chronica
+∞
8.4
8
*
36802
ICD-8 Finland
Inflammation of lachrymal glands and ducts, Obstructio, stenosis viarum lacrimalium
+∞
8.4
8
*
R01AD08
ATC
fluticasone; nasal
2.2
8.2
91
502
L04AX03
ATC
methotrexate; systemic
3.0
8.1
38
139
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.9
8.0
40
151
J01FF01
ATC
clindamycin; systemic
2.2
7.8
87
479
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
3.7
7.7
25
72
Z3229
NOMESCO Finland
Other healthcare associate professional
3.0
7.6
35
126
A05AA02
ATC
ursodeoxycholic acid; oral
9.2
7.6
15
17
UDM02
NOMESCO Finland
Sinoscopy
8.0
7.5
16
21
H04.2
ICD-10 Finland
Epiphora
82.1
7.5
8
*
L04AA06
ATC
mycophenolic acid; systemic
13.8
7.4
12
9
D07AC01
ATC
betamethasone; topical
2.0
7.4
109
666
UJF32
NOMESCO Finland
Coloscopy
2.1
7.3
85
474
S01AD03
ATC
aciclovir; ophthalmic
4.5
7.3
18
42
CCA30
NOMESCO Finland
Incision of lacrimal sac
+∞
7.3
7
*
H16.8
ICD-10 Finland
Other keratitis
+∞
7.3
7
*
S01XA18
ATC
ciclosporin; ophthalmic
+∞
7.3
7
*
A03CA02
ATC
clidinium and psycholeptics; oral
3.4
7.2
27
86
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
6.9
135
903
XCK00
NOMESCO Finland
Perimetry
3.2
6.7
27
90
H26.4
ICD-10 Finland
After-cataract
2.7
6.5
37
150
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.8
6.5
34
132
A02BA04
ATC
nizatidine; systemic
3.0
6.4
30
109
R01AD58
ATC
fluticasone, combinations; nasal
2.1
6.3
70
381
J01FA10
ATC
azithromycin; systemic
1.9
6.3
168
1230
H02.2
ICD-10 Finland
Lagophthalmos
+∞
6.3
6
*
CCD40
NOMESCO Finland
Percutaneous dacryocystorhinostomy
+∞
6.3
6
*
H20.1
ICD-10 Finland
Chronic iridocyclitis
27.3
6.3
8
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
6.3
115
748
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.7
6.2
35
141
F03
ICPC
Eye discharge
3.2
6.1
25
84
E0000UV, ,
ATC
1.9
6.1
121
806
R06AE09
ATC
levocetirizine; oral
2.4
6.0
46
215
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
224
1738
2.32
8.08
6.0
3.8
11.96
12.75
mm/h
0.44
211
1589
20
51
4.14
7.29
1.5
1.5
0.09
0.01
iu/ml
—
7
9
224
1789
2.15
6.74
9.3
6.9
77.54
77.49
u/l
0.00
214
1671
16
39
4.29
6.17
4.4
3.5
4.03
4.62
e9/l
0.42
16
39
72
401
2.06
6.12
1.3
1.3
18.98
36.13
iu/ml
1.38
19
136
16
40
4.18
5.98
4.9
4.1
53.44
61.63
%
1.76
16
40
125
846
1.85
5.93
3.9
3.1
—
—
—
0
0
158
1164
1.80
5.55
5.0
3.7
0.00
0.00
estimate
-0.00
34
215
69
391
2.01
5.55
1.3
1.3
2.76
9.96
u/ml
1.81
29
163
157
1155
1.79
5.54
6.1
4.9
0.00
0.00
estimate
-0.00
37
227
155
1149
1.76
5.21
5.0
3.7
0.00
0.00
estimate
0.50
38
247
8
6
13.66
5.11
1.1
1.0
—
—
—
0
0
22
79
2.93
4.83
2.0
1.7
—
192.00
—
0
5
135
998
1.67
4.32
6.2
4.3
35.19
35.45
g/l
0.21
125
938
88
587
1.72
4.10
2.3
2.1
3.00
3.23
mg/l
0.46
77
492
245
2153
1.94
3.91
5.8
4.8
1.73
1.91
mu/l
2.00
229
1959
93
643
1.66
3.75
6.0
4.0
0.00
0.00
estimate
-0.00
34
228
148
1148
1.60
3.73
6.2
6.8
1.21
1.22
mmol/l
0.28
124
978
262
2377
2.17
3.51
21.4
16.1
3.99
3.95
mmol/l
1.56
255
2303
79
533
1.67
3.46
1.5
1.2
2.26
1.77
u/ml
0.12
24
129
211
1801
1.65
3.42
5.1
4.0
14.82
14.88
pmol/l
0.13
195
1627
261
2372
2.11
3.36
21.2
16.1
139.41
139.66
mmol/l
0.85
256
2302
12
33
3.75
3.33
1.8
1.8
—
—
—
0
0
12
33
3.75
3.33
1.8
1.8
—
—
—
0
0
31
159
2.06
3.24
2.0
1.6
—
—
—
0
0
19
79
2.50
3.21
2.3
1.6
—
—
—
0
0
119
901
1.55
3.19
5.5
3.8
—
—
—
0
0
164
1333
1.54
3.17
11.2
8.4
3.79
4.09
e9/l
1.24
148
1171
256
2321
1.95
3.16
19.4
13.8
21.04
23.45
mg/l
0.51
220
1801
92
661
1.58
3.09
4.2
3.6
15.03
8.51
mg/mmol
0.44
57
429
14
51
2.83
3.03
2.1
1.6
—
—
—
0
0
11
31
3.65
3.02
1.5
1.7
—
—
—
0
0
9
21
4.39
3.02
2.0
1.6
—
—
—
0
0
9
21
4.39
3.02
2.0
1.6
—
—
—
0
0
127
985
1.52
3.00
2.6
2.3
81.40
77.01
nmol/l
0.96
117
874
267
2467
2.18
2.96
13.7
9.7
24.67
24.28
u/l
0.15
260
2372
14
52
2.78
2.93
1.9
1.6
—
—
—
0
0
61
402
1.66
2.89
1.6
1.6
—
—
—
0
0
9
23
4.00
2.80
1.0
1.0
—
—
—
0
0
136
1082
1.49
2.79
21.3
14.3
1.35
1.27
inr
0.50
47
321
137
1094
1.48
2.74
10.9
5.2
28.96
28.02
%
0.49
129
1031
92
678
1.53
2.71
3.7
2.9
0.31
0.40
e6/l
0.31
72
511
17
73
2.41
2.71
2.6
1.3
—
—
—
0
0
274
2575
2.41
2.60
27.8
20.4
254.17
252.25
e9/l
0.17
269
2512
52
338
1.66
2.60
2.7
1.8
29.33
29.53
s
0.10
52
327
274
2576
2.41
2.58
27.8
20.4
39.33
39.77
%
0.51
264
2417
132
1056
1.46
2.57
6.4
5.6
1.22
1.22
mmol/l
0.15
124
970
5
7
7.24
2.56
1.0
1.0
1735.40
1745.00
miu/ml
—
5
7
6
11
5.54
2.55
5.3
1.7
—
—
—
0
0
54
357
1.63
2.52
2.2
1.9
—
—
—
0
0
72
517
1.52
2.36
2.5
1.7
0.71
1.13
mg/l
2.02
55
407
249
2283
1.68
2.35
5.1
4.7
2.76
2.74
mmol/l
0.15
232
2090
40
250
1.70
2.31
2.2
1.8
—
—
—
0
0
129
1047
1.42
2.24
3.8
2.7
110.32
113.28
ug/l
0.07
120
950
147
1231
1.40
2.09
7.0
5.8
10.84
10.87
umol/l
0.01
139
1172
39
249
1.66
2.09
2.2
1.7
—
—
—
0
0
131
1079
1.39
2.04
10.8
4.9
56.42
57.50
%
0.54
123
1018
43
284
1.60
2.02
5.1
5.9
104.00
104.26
mmol/l
0.14
43
284
243
2238
1.56
1.98
4.5
4.2
4.65
4.67
mmol/l
0.08
225
2059
8
27
3.02
1.95
1.4
1.7
—
—
—
0
0
6
16
3.81
1.94
1.7
3.3
—
—
—
0
0
84
647
1.42
1.91
3.2
3.3
1292.87
1630.76
ng/l
0.41
69
552
7
22
3.23
1.89
3.6
1.2
—
—
—
0
0
5
12
4.22
1.83
1.0
2.9
355.80
1040.00
u/ml
—
5
12
5
12
4.22
1.83
2.6
3.6
108.80
100.83
%
—
5
12
74
564
1.42
1.77
2.5
2.7
8378.81
8724.06
umol/l
0.02
63
489
90
710
1.39
1.77
3.7
1.9
110.30
208.44
u/l
2.62
84
669
92
730
1.38
1.75
3.4
2.4
57.17
55.30
u/l
0.16
83
680
12
55
2.23
1.70
1.2
1.1
—
—
—
0
0
16
83
1.98
1.68
1.6
1.3
—
—
—
0
0
6
19
3.20
1.67
1.3
2.0
—
—
—
0
0
6
19
3.20
1.67
1.3
2.0
—
—
—
0
0
6
19
3.20
1.67
1.3
2.0
—
—
—
0
0
7
25
2.84
1.66
3.6
1.9
—
—
—
0
0
32
208
1.61
1.62
7.7
3.0
1.53
2.17
mmol/l
0.60
26
170
7
26
2.73
1.59
1.6
1.7
—
—
—
0
0
12
57
2.15
1.57
2.9
3.0
—
—
—
0
0
236
2189
1.44
1.56
16.2
12.8
79.71
80.51
ml/min/173m2
0.20
189
1794
239
2222
1.45
1.56
5.0
4.4
5.85
5.93
mmol/l
0.52
218
2018
5
15
3.37
1.53
1.4
1.6
—
—
—
0
0
64
489
1.40
1.51
1.8
1.8
471.18
16750445.76
pmol/l
0.50
50
400
7
28
2.54
1.46
2.1
2.3
11.11
4.53
umol/l
—
7
22
5
16
3.16
1.44
6.4
1.6
417.20
627.45
e6/l
—
5
11
5
16
3.16
1.44
1.4
1.7
73.80
72.50
umol/l
—
5
16
6
22
2.76
1.44
1.0
1.2
—
—
—
0
0
74
587
1.35
1.38
1.6
1.6
1.31
1.37
mmol/l
0.34
60
492
238
2225
1.41
1.37
4.4
4.2
1.47
1.50
mmol/l
0.66
219
2045
9
43
2.13
1.31
1.8
1.2
—
—
—
0
0
9
43
2.13
1.31
1.8
1.2
—
—
—
0
0
30
203
1.53
1.31
5.5
9.8
121.43
120.11
g/l
0.14
30
195
6
24
2.53
1.31
1.3
1.2
—
—
—
0
0
6
24
2.53
1.31
1.2
1.7
—
—
—
0
0
6
24
2.53
1.31
1.3
1.2
—
—
—
0
0
13
69
1.93
1.30
1.8
1.4
—
—
—
0
0
18
107
1.73
1.29
1.1
1.0
—
—
—
0
0
8
36
2.26
1.25
1.1
1.1
—
—
—
0
0
10
49
2.08
1.23
1.4
1.3
—
—
—
0
0
61
479
1.35
1.22
4.9
4.5
2.39
2.88
ug/l
0.25
53
426
167
1499
1.27
1.21
4.5
3.0
47.66
45.23
u/l
0.13
157
1405
12
64
1.91
1.20
1.9
4.1
26.54
24.71
mg/l
—
7
48
12
64
1.91
1.20
1.9
4.1
42.47
143.30
mg/l
—
7
48
15
87
1.76
1.17
3.1
10.5
1.35
1.60
%
0.79
15
77
0
33
0.00
1.17
0.0
1.4
—
—
—
0
0
5
20
2.53
1.15
1.2
1.2
—
—
—
0
0
5
20
2.53
1.15
1.2
1.2
—
—
—
0
0
7
31
2.29
1.11
1.7
2.1
3.57
129.96
u/ml
—
7
31
5
21
2.40
1.09
1.2
1.2
—
—
—
0
0
5
21
2.40
1.09
2.4
1.8
—
—
—
0
0
5
21
2.40
1.09
1.2
1.2
—
—
—
0
0
5
21
2.40
1.09
1.2
1.2
—
—
—
0
0
224
2102
1.30
1.04
6.4
5.5
40.16
39.81
mmol/mol
0.21
212
1951
34
249
1.41
1.04
3.9
3.4
—
—
—
0
0
12
68
1.80
1.02
1.3
1.1
—
—
—
0
0
12
68
1.80
1.02
1.3
1.1
—
—
—
0
0
29
208
1.44
0.99
5.3
5.4
1.30
1.31
mmol/l
0.03
29
200
5
23
2.19
0.98
2.4
1.7
—
—
—
0
0
21
141
1.53
0.98
5.4
10.7
24.35
24.53
mmol/l
0.09
21
132
228
2151
1.29
0.97
4.0
3.8
1.28
1.27
mmol/l
0.17
208
1966
9
51
1.79
0.95
1.8
1.3
—
—
—
0
0
47
369
1.33
0.95
3.7
4.1
24.11
21.61
%
0.47
26
170
9
52
1.75
0.93
1.0
1.4
—
—
—
0
0
94
809
1.24
0.93
3.0
3.2
2.37
2.35
mmol/l
0.54
85
714
20
135
1.52
0.92
1.5
1.9
—
—
—
0
0
8
42
1.93
0.89
1.4
1.6
—
—
—
0
0
10
56
1.81
0.89
21.2
3.5
1.66
1.50
mg/l
—
10
48
10
56
1.81
0.89
1.7
1.1
—
—
—
0
0
107
940
1.22
0.86
2.1
2.0
98.02
96.25
pmol/l
0.13
59
486
124
1106
1.21
0.86
2.8
2.5
—
—
—
0
0
24
172
1.43
0.84
1.6
2.0
—
—
—
0
0
29
216
1.38
0.83
3.3
2.2
119.14
30.96
u/l
0.59
21
175
24
173
1.42
0.82
2.2
2.5
59.30
65.11
ml/min/173m2
—
10
71
7
124
0.55
0.79
1.6
1.5
—
—
—
0
0
6
33
1.84
0.79
2.5
1.4
—
—
—
0
0
54
445
1.26
0.78
1.9
1.8
1198.85
1203.51
nmol/l
0.01
48
322
9
54
1.69
0.75
1.1
1.5
—
—
—
0
0
85
741
1.21
0.73
4.3
3.0
34.92
30.30
u/l
0.36
75
709
23
169
1.39
0.72
1.6
1.2
412.38
141.25
iu/ml
—
10
72
7
40
1.77
0.72
2.6
1.6
—
—
—
0
0
5
26
1.94
0.71
1.0
1.1
—
—
—
0
0
11
69
1.62
0.69
1.2
1.2
—
—
—
0
0
153
1414
1.18
0.67
3.5
3.1
—
—
—
0
0
64
548
1.22
0.66
2.8
2.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
10
64
1.58
0.59
1.6
1.3
—
—
—
0
0
17
123
1.41
0.59
1.3
1.3
—
—
—
0
0
98
882
1.17
0.58
5.5
3.7
29.01
77.74
ng/l
0.66
68
620
52
443
1.21
0.57
4.5
3.8
602.03
229.24
ng/l
0.32
38
342
16
116
1.40
0.55
3.5
2.3
0.59
0.69
%
0.65
16
116
16
119
1.36
0.49
3.6
2.3
1.18
1.24
%
0.08
16
119
7
48
1.47
0.47
2.1
1.4
—
—
—
0
0
34
284
1.22
0.46
3.1
2.8
0.64
0.86
ug/l
0.97
21
189
34
286
1.21
0.44
2.3
2.2
—
—
—
0
0
5
32
1.57
0.42
2.0
1.9
—
—
—
0
0
46
401
1.18
0.41
1.7
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.9
—
7.49
—
0
15
0
19
0.00
0.39
0.0
3.8
—
—
—
0
0
31
262
1.21
0.39
6.7
2.6
7.30
8.10
umol/l
0.09
24
222
9
67
1.35
0.38
2.3
2.0
—
—
—
0
0
44
386
1.17
0.37
3.4
2.7
4.27
3.47
e6/l
0.19
25
198
23
276
0.82
0.36
3.1
4.4
30.00
31.82
%
0.40
15
181
10
75
1.35
0.30
1.7
2.1
—
—
—
0
0
12
94
1.29
0.28
2.4
1.9
0.46
1.67
ug/l
1.34
12
82
30
262
1.16
0.28
2.1
2.1
—
—
—
0
0
29
254
1.16
0.26
5.7
8.5
5.18
5.08
kpa
0.25
29
239
29
254
1.16
0.26
5.7
8.5
11.64
12.70
kpa
0.62
29
241
29
254
1.16
0.26
2.6
4.3
11.99
26.36
ug/l
0.38
21
216
45
408
1.12
0.25
3.1
2.5
0.74
1.26
e6/l
1.04
25
219
59
548
1.10
0.22
1.8
1.5
19.22
21.65
nmol/l
0.65
52
467
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
480.14
—
0
7
0
12
0.00
0.21
0.0
1.0
—
44.00
—
0
7
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
6
48
1.26
0.20
2.7
1.6
—
—
—
0
0
11
90
1.23
0.19
2.3
2.0
—
—
—
0
0
5
66
0.75
0.17
1.2
2.5
23.68
24.61
mmol/l
—
5
66
8
69
1.16
0.16
1.5
1.2
—
—
—
0
0
15
130
1.16
0.16
1.5
1.7
—
—
—
0
0
29
268
1.09
0.12
12.9
7.0
—
—
—
0
0
10
85
1.18
0.12
2.1
1.8
—
—
—
0
0
17
186
0.91
0.09
1.7
1.7
—
—
—
0
0
6
75
0.80
0.07
1.3
1.4
—
—
—
0
0
17
159
1.07
0.05
3.5
2.7
47.35
53.86
u/ml
0.08
17
154
14
132
1.06
0.02
1.2
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
0.00
1.2
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
24.08
—
0
5
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_DACRYOADENITIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_DACRYOADENITIS | 1.049 [0.86, 1.27] | 0.633 |
| Birth year | 0.995 [0.99, 1.0] | 0.239 |
During the follow-up period (1.1.1998 — 31.12.2019), 219 out of 1134 females with H7_DACRYOADENITIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_DACRYOADENITIS | 1.041 [0.76, 1.42] | 0.798 |
| Birth year | 0.984 [0.97, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 98 out of 509 males with H7_DACRYOADENITIS died.
Mortality risk
Mortality risk for people of age
years, who have H7_DACRYOADENITIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.087% | 0.212% |
| 5 | 0.568% | 1.1% |
| 10 | 1.448% | 2.794% |
| 15 | 2.876% | 5.216% |
| 20 | 5.457% | 8.913% |
Relationships between endpoints
↥Index endpoint: H7_DACRYOADENITIS – Dacryoadenitis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data